The synthesis and structure-activity relationship (SAR) of a novel series of aryl piperazine napthyridinone D(2) partial agonists is described. Our goal was to optimize the affinities for the D(2), 5-HT(2A) and 5-HT(1A) receptors, such that the D(2)/5-HT(2A) ratio was greater than 5 to ensure maximal occupancy of these receptors when the D(2) occupancy reached efficacious levels. This strategy led to identification of PF-00217830 (2) with robust inhibition of sLMA (MED=0.3mg/kg) and DOI-induced head twitches in rats (31% and 78% at 0.3 and 1mg/kg) with no catalepsy observed at the highest dose tested (10 mg/kg).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2011.01.059 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expansion of the Structure-Activity Relationship Profile of Triaminopyrimidines as Inhibitors of Caspase-1.
Chem Biol Drug Des
December 2024
Department of Chemistry, DePaul University, Chicago, Illinois, USA.
Caspase-1 is a sought-after therapeutic target for inflammatory conditions due to its role in activation and release of pro-inflammatory cytokines, but there has been little success getting drugs into the clinic. We have previously shown triaminopyrimidines such as CK-1-41 are potent, reversible small molecule inhibitors of caspase-1, likely binding in an allosteric site within the enzyme. A series of analogs of CK-1-41 were synthesized and tested against caspase-1 to develop a more robust structure-activity relationship profile.
View Article and Find Full Text PDFAn Ultra-Fast Green UHPLC-MS/MS Method for Assessing the In Vitro Metabolic Stability of Dovitinib: In Silico Study for Absorption, Distribution, Metabolism, Excretion, Metabolic Lability, and DEREK Alerts.
Medicina (Kaunas)
October 2024
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Article Synopsis
- Dovitinib (DVB) is a newly FDA-approved oral medication aimed at treating advanced juvenile solid tumors like osteosarcoma and has received permission for clinical trials by Oncoheroes as of September 2023.
- A novel ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed to measure DVB levels in human liver microsomes, adhering to FDA bioanalytical validation standards.
- The method demonstrated good accuracy, with inter-day precision ranging from -0.56% to 9.33% and intra-day precision from 0.28% to 7.28%, alongside a low limit of quantification of 1 ng/mL, confirming its ecological sustainability and
Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis.
RSC Adv
August 2024
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt +202 35727556 +202 35676602.
A series of novel piperazine-based bis(thiazoles) 13a-d were synthesized in moderate to good yields reaction of the bis(thiosemicarbazones) 7a, b with an assortment of -acetyl--aryl-hydrazonoyl chlorides 8a-f. Similar treatment of the bis(thiosemicarbazone) 7a, b with -aryl--phenylhydrazonoyl chlorides 10a, b afforded the expected bis(thiadiazole) based piperazine products 13b-d in reasonable yields. Cyclization of 7a, b with two equivalents of α-haloketones 14a-d led to the production of the corresponding bis(4-arylthiazol)piperazine derivatives 15a-h in good yields.
View Article and Find Full Text PDFUnlocking the potential of higher-molecular-weight 5-HTR ligands: Synthesis, affinity, and ADMET examination.
Bioorg Chem
October 2024
Maj Institute of Pharmacology Polish Academy of Sciences, Smetna 12, 31-343 Kraków, Poland. Electronic address:
An increasing number of drugs introduced to the market and numerous repositories of compounds with confirmed activity have posed the need to revalidate the state-of-the-art rules that determine the ranges of properties the compounds should possess to become future drugs. In this study, we designed a series of two chemotypes of aryl-piperazine hydantoin ligands of 5-HTR, an attractive target in search for innovative CNS drugs, with higher molecular weight (close to or over 500). Consequently, 14 new compounds were synthesised and screened for their receptor activity accompanied by extensive docking studies to evaluate the observed structure-activity/properties relationships.
View Article and Find Full Text PDFA nitrilotriacetic acid (NTA) complex of Cu(ii) supported on silica-coated nanosized magnetite FeO@SiO-Pr-DEA-[NTA-Cu(ii)] was prepared as a new well-defined magnetically separable nanomaterial and fully characterized IR, XRD, FESEM, TEM, TGA, DLS, BET, VSM, solid-state UV-vis spectroscopy, EDX, ICP-OES, and FESEM-EDX map analyses. Thereafter, it was successfully applied as a new easily magnetically separable and reusable heterogeneous nanocatalyst for the Buchwald-Hartwig C-N bond formation reaction in DMF at 110 °C. Using this method, various kinds of nitrogen heterocycles, such as imidazoles, 2-methyl-1-imidazole, benzimidazole, indole, and 10-phenothiazine as well as aliphatic secondary amines such as piperidine, piperazine, morpholine, dimethylamine, and diethylamine, were reacted with aryl halide compounds, and the desired products were obtained with good to excellent yields.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!